Jhpiego
47
2
5
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.6%
5 terminated/withdrawn out of 47 trials
88.1%
+1.6% vs industry average
9%
4 trials in Phase 3/4
5%
2 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (47)
Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)
Role: collaborator
Pharmacy-based PrEP Delivery in Kenya
Role: collaborator
SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)
Role: lead
The Role of Gender Transformative Interventions to Strengthen Gender Equity and Improve Immunization Outcomes
Role: lead
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Role: collaborator
Integrated HPV Vaccination and Adolescent Health in Tanzania
Role: lead
Injectable Contraception Cohort Study in Punjab, Pakistan
Role: lead
Integrated HPV Vaccination and Adolescent Health in Ivory Coast
Role: lead
A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth
Role: collaborator
The CATALYST Study
Role: collaborator
Birth Companion Intervention in Ethiopia, Kenya and Nigeria
Role: lead
Feasibility and Acceptability of Butterfly iQ
Role: lead
Family Led Postnatal Care in Ethiopia
Role: lead
Ethiopia Group Antenatal Care Study at the Health Post Level
Role: lead
Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania
Role: collaborator
Impact Evaluation of a Targeted mHealth Intervention to Improve Uptake of Postpartum Contraception in Kenya
Role: collaborator
Malaria Therapeutic Efficacy Study, Rwanda
Role: lead
Malaria Therapeutic Efficacy Study (TES) Kenya
Role: lead
Testing Gender-based Violence Response in Family Planning and Antenatal Care Services in Nigeria
Role: lead
TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study
Role: lead